The Diethylcarbamazine Delays and Decreases the NETosis of Polymorphonuclear Cells of Humans with DM Type 2

Figure 5

NETosis shown by PMNs after incubation with DEC at 0, 15, 30, 60, 120, and 180 minutes post challenging with PMA and indirectly measured by DAPI’s intensity of fluorescence (IF U). DM2: diabetic volunteer group; healthy: healthy volunteer group. Repeated measure analysis of variance. The marks represent the average of 5 measurements of IF in seven separate sample runs ().